Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation

Bone Marrow Transplant. 1999 Nov;24(9):1005-7. doi: 10.1038/sj.bmt.1702010.

Abstract

Acute graft-versus-host disease (GVHD) is the most important complication of allogeneic bone marrow transplantation. We investigated the possibility of predicting severe acute GVHD using plasma interleukin-10 levels in 31 patients who underwent allogeneic bone marrow transplantation. In patients with acute GVHD, the interleukin-10 (IL-10) level increased significantly from the aplastic phase through the leukocyte recovery phase after transplantation (P < 0.05, paired t-test). The ratio of the IL-10 level in the aplastic phase to that in the leukocyte recovery phase was significantly correlated with the severity of acute GVHD (P < 0. 05, t-test), and the incidence of grade III or IV disease was significantly increased (P < 0.0001). Since IL-10 antagonizes various other cytokines that induce acute GVHD, determination of the IL-10 level is equivalent to assessing the total production of cytokines promoting GVHD. The ratio of the IL-10 level in the aplastic phase to that in the recovery phase seems to be useful for predicting the subsequent risk of acute GVHD.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Bone Marrow Transplantation / adverse effects*
  • Female
  • Graft vs Host Disease / etiology*
  • Graft vs Host Disease / immunology*
  • Hematopoiesis
  • Humans
  • Interleukin-10 / blood*
  • Male
  • Risk Factors
  • Transplantation, Homologous

Substances

  • Interleukin-10